Wolfe Repass files Rule 144 to sell 13,796 shares
Wolfe Repass reported proposed sales of 13,796 common shares under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Wolfe Repass reported proposed sales of 13,796 common shares under Rule 144. The filing lists the securities as restricted stock vesting on 02/23/2026 and shows recent dispositions during February 2026, including 21,857, 12,406, and 4,179 shares sold on separate dates.
The securities are held at Fidelity Brokerage Services LLC and the filing identifies NASDAQ as the market. The filing appears to relate to compensation vesting and subsequent Rule 144 sale notices.
Insights
Rule 144 notice documenting an issuer-related vesting and recent open-market dispositions.
The filing lists 13,796 common shares described in the "Securities To Be Sold" line and notes a 02/23/2026 restricted stock vesting event identified as compensation. It also itemizes three prior February 2026 dispositions of 21,857, 12,406, and 4,179 shares.
Timing and cash‑flow treatment are not detailed beyond the sale dates. Subsequent reports or broker confirmations would show actual sale proceeds and final transfer timing.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Is the Form 144 tied to compensation vesting for FLD?
AI-generated analysis. How Rhea-AI works. Not financial advice.